SCHEMBL9535141

SCHEMBL9535141

Cc1cccc2nc3sccn3c(=O)c12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GAA P10253 4/20 0.49
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
PKM P14618 7/20 0.42
PARP1 P09874 1/20 0.42
ELANE P08246 1/20 0.42
LMNA P02545 1/20 0.41
PIK3CD O00329 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770762 0.82 CYP1A2 (0.43) CYP1A2TDP1GAASMN1; SMN2HSD17B10
SCHEMBL9534383 0.82 TDP1 (0.50) CYP1A2TDP1GAAMAPTSMN1; SMN2
SCHEMBL9534833 0.82 CYP1A2 (0.50) CYP1A2TDP1GAAMAPTSMN1; SMN2
SCHEMBL9536192 0.82 CYP1A2 (0.53) CYP1A2TDP1GAASMN1; SMN2HSD17B10
SCHEMBL9534961 0.82 CYP1A2 (0.43) CYP1A2TDP1GAAMAPTSMN1; SMN2
SCHEMBL9534033 0.82 PKM (0.50) CYP1A2TDP1MAPTSMN1; SMN2HSD17B10
SCHEMBL9534657 0.80 CYP1A2 (0.42) CYP1A2TDP1GAAMAPTSMN1; SMN2
SCHEMBL10696638 0.79 CYP1A2 (0.40) CYP1A2TDP1GAASMN1; SMN2HSD17B10
SCHEMBL9533900 0.79 KDM4E (0.43) CYP1A2TDP1GAAMAPTHSD17B10
SCHEMBL9536137 0.79 DHFR (0.48) CYP1A2TDP1GAASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0263523-B1 Process for the preparation of thiazolo [2,3-b] quinazolones BASF AG (DE) 1993-12-29 EP disclosed
US-5030727-A Reacting an anthronilide derivative with a thiazole derivative or a fluorozuinazolone with a neucleophile BASF AKTIENGESELLSCHAFT (DE) 1991-07-09 US disclosed
EP-0263523-A2 Process for the preparation of thiazolo [2,3-b] quinazolones BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed